Taken together, these findings indicate that MC4R signaling strongly modulates D1R signaling, making it an interesting target for pharmacotherapies to combat psychopathologies such as addiction and obesity. Here, MC4R is linked to obesity due to melanocortin 4 receptor deficiency.